US Patent

US9731121 — Switch validation circuit and method

Formulation · Assigned to Incline Therapeutics Inc · Expires 2031-10-17 · 5y remaining

Vulnerability score 48/100 Strong — defensible against typical IPR challenges

What this patent protects

This patent protects a switch-operated device that delivers a therapeutic agent, such as a drug, when certain conditions are met.

USPTO Abstract

A switch-operated therapeutic agent delivery device is described. Embodiments of the operated therapeutic agent delivery device include a switch that can be operated by a user, a device controller connected to the switch through a switch input where the device can actuate the device when certain predetermined conditions are met, following performance of both a digital switch validation test and an analog switch validation test.

Drugs covered by this patent

Patent Metadata

Patent number
US9731121
Jurisdiction
US
Classification
Formulation
Expires
2031-10-17
Drug substance claim
No
Drug product claim
Yes
Assignee
Incline Therapeutics Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.